IN VITRO ANTIMICROBIAL SUSCEPTIBILITY AND TREATMENT OUTCOMES OF MOLECULAR DIAGNOSED MYCOBACTERIUM KANSASII PULMONARY DISEASE

被引：0
|
作者：
Liu, Chia-Jung [1 ]
Hsueh, Po-Ren [1 ,2 ]
Chien, Jung-Yien [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO166
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [21] A Case of Pulmonary Mycobacterium kansasii Disease Complicated with Tension Pneumothorax
    Boo, Ki Yung
    Lee, Jong Hoo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2015, 78 (04) : 356 - 359
  • [22] Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis
    Oermann, CM
    Starke, JR
    Seilheimer, DK
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (02) : 257 - 259
  • [23] In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea
    Park, Sunghoon
    Kim, Shinok
    Park, Eun Mi
    Kim, Hojoong
    Kwon, O. Jung
    Chang, Chulhun L.
    Lew, Woo Jin
    Park, Young Kil
    Koh, Won-Jung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (01) : 49 - 52
  • [24] Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study
    Munoz-Munoz, Lara
    Ainsa, Jose A.
    Ramon-Garcia, Santiago
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [25] PULMONARY TUBERCULOSIS FOLLOWING SUCCESSFUL TREATMENT OF PULMONARY INFECTION WITH MYCOBACTERIUM-KANSASII
    ZVETINA, JR
    NATHAN, N
    FACEN, H
    CHEST, 1976, 70 (06) : 786 - 788
  • [26] PULMONARY DISEASE DUE TO RIFAMPIN-RESISTANT MYCOBACTERIUM KANSASII IN AN ADOLESCENT
    Polat, Meltem
    Parlakay, Aslinur Ozkaya
    Tapisiz, Anil
    Cakmak, Pinar
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2020, 56 (03) : 489 - 489
  • [27] Pulmonary Mycobacterium kansasii infection: Comparison of the clinical features, treatment and outcome with pulmonary tuberculosis
    Evans, SA
    Colville, A
    Evans, AJ
    Crisp, AJ
    Johnston, IDA
    THORAX, 1996, 51 (12) : 1248 - 1252
  • [28] TREATMENT OF PULMONARY-DISEASE DUE TO MYCOBACTERIUM-KANSASII - RECENT EXPERIENCE WITH REGIMENS CONTAINING RIFAMPIN
    PEZZIA, W
    RALEIGH, JW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1974, 109 (06): : 716 - 716
  • [29] Treatment of pulmonary disease caused by Mycobacterium kansasii: Results of 18 vs 12 months' chemotherapy - Reply
    Sauret, J
    TUBERCLE AND LUNG DISEASE, 1995, 76 (06): : 583 - 583
  • [30] The clinical characteristics of Mycobacterium fortuitum pulmonary disease and the treatment outcomes
    Kim, Sae Rom
    Jhun, Byung Woo
    RESPIROLOGY, 2023, 28 : 124 - 124
12345